ArticleBlood2019
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
Open access · bronzeAbstract read
In one paragraph
Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.
- A Diagnostic Approach in Large B-Cell Lymphomas According to the Fifth World Health Organization and International Consensus Classifications and a Practical Algorithm in Routine Practice.International journal of molecular sciences · 2024Guideline
- A genetic profiling guideline to support diagnosis and clinical management of lymphomas.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024Guideline
- [Diagnostic challenges in pediatric lymphomas].Pathologie (Heidelberg, Germany) · 2026Review
- Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis.Cancers · 2026Review
- High-grade B-cell lymphomas: high difficulties to diagnose and treat?Hematology. American Society of Hematology. Education Program · 2025Review
- A rare case of large B-cell lymphoma with IRF4 rearrangement and concomitant 11q aberrations: a diagnostic pitfall in the molecular era.Virchows Archiv : an international journal of pathology · 2025Article
- "In situ" MYC rearrangement and amplification as a secondary change in a case of High-grade B cell lymphoma with 11q aberration.Annals of hematology · 2025Article
- Pediatric lymphomas: overview and diagnostic challenges.Virchows Archiv : an international journal of pathology · 2025Review
- microRNA Profile of High-Grade B-Cell Lymphoma with 11q Aberration.International journal of molecular sciences · 2024Article
- Discovery of first-in-class PROTACs targeting maternal embryonic leucine zipper kinase (MELK) for the treatment of Burkitt lymphoma.RSC medicinal chemistry · 2024Article
- What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?Journal of hematopathology · 2024Review
- Genetic alterations in mature B- and T-cell lymphomas - a practical guide to WHO-HAEM5.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024Article
- Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.Virchows Archiv : an international journal of pathology · 2024Review
- Comparison of the World Health Organisation and International Consensus Classification of haematolymphoid tumours.Journal of the colleges of medicine of South Africa · 2024Review
- The 2022 classifications of lymphoid neoplasms : Keynote.Pathologie (Heidelberg, Germany) · 2023Review
- [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2023Article
- Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.Virchows Archiv : an international journal of pathology · 2023Review
- [Classification of aggressive B-cell lymphomas : News and open questions].Pathologie (Heidelberg, Germany) · 2023Review
- Review
- High-grade B-cell lymphoma with 11q aberrations: A single-center study.Journal of clinical and experimental hematopathology : JCEH · 2023Article
Corrections and comments
- Commented on by
Authors and funding
22 authors at 11 institutions in 4 countries.
Rabea WagenerInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Julian SeufertBioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Francesco RaimondiCell Networks, Bioquant, and.
Susanne BensInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Kortine KleinheinzInstitute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg, Germany.
Inga NagelInstitute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Janine AltmüllerCologne Center for Genomics, Center for Molecular Medicine Cologne and.
Holger ThieleCologne Center for Genomics, University of Cologne, Cologne, Germany.
Daniel HübschmannDivision of Theoretical Bioinformatics, DKFZ, Heidelberg, Germany.ORCID 0000-0002-6041-7049
Christian W KohlerInstitute of Functional Genomics, University of Regensburg, Regensburg, Germany.
Peter NürnbergCologne Center for Genomics, Center for Molecular Medicine Cologne and.
Rex Au-YeungHematopathology Section, Christian-Albrechts University, Kiel, Germany.ORCID 0000-0002-3137-0886
Birgit BurkhardtDepartment of Pediatric Hematology and Oncology and NHL-BFM Study Center, University Hospital Münster, Münster, Germany.
Heike HornDepartment of Clinical Pathology, Robert-Bosch Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Lorenzo LeonciniSection of Pathology, Department of Medical Biotechnology, University of Siena, Siena, Italy.
Elaine S JaffeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and.
German OttDepartment of Clinical Pathology, Robert-Bosch Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Grzegorz RymkiewiczFlow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland.
Matthias SchlesnerBioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-5896-4086
Robert B RussellCell Networks, Bioquant, and.ORCID 0000-0002-1905-4717
Wolfram KlapperHematopathology Section, Christian-Albrechts University, Kiel, Germany.
Reiner SiebertInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Christian-Albrechts-Universität zu Kiel · DEUniversität Ulm · DEGerman Cancer Research Center · DEHeidelberg University · DERobert Bosch Hospital · DENational Institutes of Health · USThe Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity Hospital Münster · DEUniversity of Cologne · DEUniversity of Regensburg · DEUniversity of Siena · IT
Funding
Hematopathology DiagnosisZIABC011070 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$14.5MAbstract
The new recently described provisional lymphoma category Burkitt-like lymphoma with 11q aberration comprises cases similar to Burkitt lymphoma (BL) on morphological, immunophenotypic and gene-expression levels but lacking the IG-
Indexed as
Chromosome AberrationsMutationAdolescentAdultATPases Associated with Diverse Cellular ActivitiesBiomarkers, TumorBurkitt LymphomaChildChild, PreschoolChromosomes, Human, Pair 11DNA-Binding ProteinsDNA HelicasesFemaleFollow-Up StudiesHumansMaleATPases Associated with Diverse Cellular ActivitiesBiomarkers, TumorDNA-Binding ProteinsDNA HelicasesINO80 protein, humanMYC protein, humanNFRKB protein, humanProto-Oncogene Proteins c-myc
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.